2017
Pharmacogenomics of 17‐alpha hydroxyprogesterone caproate for recurrent preterm birth: a case–control study
Manuck T, Watkins W, Esplin, Biggio J, Bukowski R, Parry S, Zhan H, Huang H, Andrews W, Saade G, Sadovsky Y, Reddy U, Ilekis J, Yandell M, Varner M, Jorde L, Research T. Pharmacogenomics of 17‐alpha hydroxyprogesterone caproate for recurrent preterm birth: a case–control study. BJOG An International Journal Of Obstetrics & Gynaecology 2017, 125: 343-350. PMID: 28139890, DOI: 10.1111/1471-0528.14485.Peer-Reviewed Original ResearchConceptsRecurrent preterm birthPreterm birthSuccessful prolongationDefinition ADefinition BSingleton spontaneous preterm birthSpontaneous preterm birthTertiary care centerCase-control studyWhole-exome sequencingUntreated pregnanciesGestational ageHydroxyprogesterone caproateSignificant prolongationPregnancyExome sequencingProlongationWomenPharmacogenetic genesBirthGene ontology pathwaysIntegrated DiscoveryOntology pathwaysNovel analytic approach
2016
12: Genetic variation may influence response to 17-alpha hydroxyprogesterone caproate (17P) for recurrent preterm birth (PTB) prevention
Manuck T, Watkins S, Esplin M, Parry S, Zhang H, Huang H, Biggio J, Bukowski R, Saade G, Andrews W, Baldwin D, Sadovsky Y, Reddy U, Ilekis J, Varner M, Yandell M, Jorde L. 12: Genetic variation may influence response to 17-alpha hydroxyprogesterone caproate (17P) for recurrent preterm birth (PTB) prevention. American Journal Of Obstetrics And Gynecology 2016, 214: s9-s10. DOI: 10.1016/j.ajog.2015.10.034.Peer-Reviewed Original ResearchRecurrent preterm birth preventionGenetic variationPreterm birth preventionBirth preventionHydroxyprogesterone caproate
2015
Predictors of response to 17-alpha hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth
Manuck TA, Esplin MS, Biggio J, Bukowski R, Parry S, Zhang H, Huang H, Varner MW, Andrews W, Saade G, Sadovsky Y, Reddy UM, Ilekis J, Research E. Predictors of response to 17-alpha hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth. American Journal Of Obstetrics And Gynecology 2015, 214: 376.e1-376.e8. PMID: 26692181, PMCID: PMC4803498, DOI: 10.1016/j.ajog.2015.12.010.Peer-Reviewed Original ResearchConceptsSpontaneous preterm birthPrevious spontaneous preterm birthRecurrent spontaneous preterm birthDelivery gestational ageRecurrent preterm birthPreterm birthSimilar gestational ageGestational ageHydroxyprogesterone caproateSingleton spontaneous preterm birthEarly spontaneous preterm birthFirst-degree family historyPreterm birth preventionHigh-risk womenPlanned secondary analysisPredictors of responseChi-square testPenultimate pregnancyPregnancy characteristicsNeonatal morbidityPregnancy coursePreterm pregnanciesBirth preventionCurrent pregnancyRegression models560: Predictors of response to 17-alpha hydroxyprogesterone caproate (17P) for prevention of recurrent spontaneous preterm birth (SPTB)
Manuck T, Esplin M, Parry S, Zhang H, Biggio J, Bukowski R, Saade G, Sadovsky Y, Baldwin D, Andrews W, Huang H, Reddy U, Ilekis J, Varner M. 560: Predictors of response to 17-alpha hydroxyprogesterone caproate (17P) for prevention of recurrent spontaneous preterm birth (SPTB). American Journal Of Obstetrics And Gynecology 2015, 212: s279. DOI: 10.1016/j.ajog.2014.10.606.Peer-Reviewed Original ResearchSpontaneous preterm birthRecurrent spontaneous preterm birthPredictors of responsePreterm birthHydroxyprogesterone caproatePrevention